Gilenya
FDA Approves First Generic Versions of Gilenya
The FDA has approved three applications for first generic versions of Novartis’ Gilenya (fingolimod) capsules ...
DECEMBER 5, 2019
FDA Granted a New Indication for Gilenya to Treat RMS in Children
Gilenya is the first DMT indicated for children and adolescents with relapsing forms of multiple sclerosis.
MAY 16, 2018
$19.6 Million from PCORI Supports MS Research
Funding covers four major new studies assessing the comparative effectiveness of several MS therapies.
JULY 25, 2016
Load more